Abstract: Analysis of a detailed mathematical model of the insulin signaling pathway yields a more quantitative understanding of the mechanisms underlying insulin resistance and its subsequent progression to type 2 diabetes. A sensitivity analysis of the model allows optimization of input perturbation as well as state measurement selection for experimental parameter identification. Finally, a stochastic version of the model yields interesting results on the impact of cellular noise on insulin signaling.
INTRODUCTION
Overabundant food supply combined with an increasingly sedentary lifestyle, particularly in developed nations, has led to a dramatic increase in the incidence of type 2 diabetes mellitus (T2DM). T2DM has been linked with insulin resistance -a reduced sensitivity of glucose concentration to changes in insulin concentration. Insulin resistance has been hypothesized to be linked to a number of defects in insulin signaling pathways.
One of the functions of insulin is control of cellular glucose uptake in muscle and adipose tissue. This control is carried out through the following signaling cascade (Sesti [2006] ). First, insulin binds insulin receptor, which causes receptor autophosphorylation and activation. Activated insulin receptor then phosphorylates insulin receptor substrate-1 (IRS1), which subsequently forms a complex with phosphatidylinositol-3-kinase (PI3K). The IRS1-PI3K complex catalyzes the production of phosphatidylinositol triphosphate (PIP 3 ) which then interacts allosterically with phosphosinositide-dependent kinase 1 (PDK1). The PIP 3 -PDK1 complex phosphorylates protein kinases Akt and protein kinase C (PKCζ). Activated Akt and PKCζ, through an unknown mechanism, trigger glucose transporter (GLUT4) translocation from an internal compartment to the cell membrane. With GLUT4 at the cell membrane, a cell can then uptake glucose from its environment.
This pathway is regulated by the action of a number of other proteins. For example, protein tyrosine phosphatase 1B (PTP1B) dephosphorylates activated insulin receptors and IRS1. In addition, SHIP2 and PTEN (lipid phos- phatases) deactivate PIP 3 into PI(3,4)P 2 and PI(4,5)P 2 , respectively.
Notably, two feedback loops modulate the effects of the insulin signaling pathway. Akt can phosphorylate PTP1B, impairing the function of PTP1B as a negative signaling element, resulting in net positive feedback. PKCζ can serine phosphorylate IRS1, which impairs formation of IRS1/PI3K complex, resulting in net negative feedback (Sedaghat et al. [2002] ).
With this information, we use the tools of systems biology, specifically sensitivity analysis and stochastic simulation, to model and analyze the insulin signaling pathway. We can then use our analysis of the model to provide recommendations for experimental work, which, in turn, guides model improvement. With sufficient iteration of model improvement and experiment, it may then be possible to explain why certain network perturbations can cause insulin resistance and to identify perturbations that may be useful for treatment (Kitano et al. [2004] ).
MODEL
Currently, the most mechanistically detailed published model of the insulin signaling pathway was developed by Sedaghat et al. [2002] . Two variations of the model were proposed -one without the feedback mechanisms and one with feedback. Differential equations, derived primarily using mass-action principles, were used to describe the timevarying concentrations of 21 state variables, as illustrated in Fig. 1 .
One submodel adds an insulin receptor recycling model to a previously published model of insulin-receptor binding (Wanant and Quon [2000] 
Results and analysis
Optimal insulin input selection One strategy to maximize parameter estimation accuracy is to vary insulin input into the system. A number of simple insulin input profiles were analyzed for maximum parameter identification in the model with feedback: 15-minute pulse, 5-minute pulse, step, upward ramp, downward ramp, 1-minute pulse, 0.5-minute impulse, and two 1-minute impulses, spaced 30 minutes apart. The peak values for each insulin input was chosen to be 10 −7 M , (as by Sedaghat) to compare similar insulin dosages. The inputs were ranked first by number of identifiable parameters (out of 31), then by A-optimality, with an FIM including all 21 state measurements.
As shown in Table 1 , the number of identifiable parameters ranges from 19 to 21 for this variety of insulin inputs, with the best result being the 1-minute pulse. Of the inputs with 21 identifiable parameters, each identifies the same parameters. Therefore, we conclude that input dynamics should have a small but quantifiable effect on the identifiability of model parameters.
An additional point to be made is that while the model without feedback has fewer parameters than the one with (29 to 31), the model with feedback is more readily identifiable. For example, for the 15-minute insulin pulse input, 65% of the parameters can be identified in the model with feedback, compared to 62% for the model without feedback. This also holds true for the insulin step input, with 61% for the model with feedback compared to 52% for the model without. The model with feedback is more identifiable because measurements of early states in the signaling pathway contain information about parameter values for reactions involved in feedback that occur further down the pathway.
Optimal measurement selection
Because identifiability was not strongly affected by insulin input dynamics, for ease of calculation, measurement selection was carried out on the 1-minute pulse, which had 21 identifiable parameters. Measurements of as many states as possible were removed from the FIM while maintaining the same number of identified parameters. Then, the FIM's including all permutations of the remaining states were calculated, with the Table 2 . Parameter identification from different measurement selections results ranked by number of identified parameters and then by A-optimality. The optimal measurement selection for each number of allowed measurements is given in Table 2 .
Input description Parameters
A measurement of only x 15 , x 17 , x 19 , x 20 , and x 21 gives 21 identifiable parameters; therefore, nearly all of the parameter information content available is included in these five states, all of which are near the end of the signaling pathway (See Appendix A.1 for more information). As this model for signal transduction is, in general, a signal cascade, the fact that a sparse measurement selection can yield high parameter information content makes sense, as measurements of later states can contain parameter information from reactions involving previous states. Even taking just one measurement (x 17 ) allows one to possibly identify 9 parameters. Although there is no guarantee that the above measurement selections will, in fact, yield the most parameter information for an arbitrary insulin input profile, the conclusion above are likely to be nearly optimal for any input selection.
Steady-state sensitivity analysis: potential drug targets
Assuming that one could determine the nominal parameter set with any degree of certainty, one might then be able to probe the model for insights concerning the longterm development of insulin resistance. Whereas the case examined by Sedaghat (2002) had a 15-minute square wave input of insulin of amplitude 10 −7 M , one might be able to simulate a more biologically relevant situation by having a uniform insulin concentration over the duration of the experiment. Due to problems with the mass balances on the components in the model, actual steady-state is not obtained in a realistic time frame and has a nonphysical total GLUT4 percentage (x 20 + x 21 ) of greater than 100%. However, by 60 minutes, the slope on surface GLUT4 percentage is fairly small, so scaled sensitivities were calculated at 60 minutes, using the insulin step input Parameter Sensitivity k 13 0.673
0.138 Table 3 . List of parameters to which the steady-state surface GLUT4 concentration is most sensitive
(−)27.3% k 11 (−)27.3% Table 4 . List of model parameter sensitivities changed most by removal of feedback mechanisms case described above with an insulin concentration of 10
M . This was done for both the model with feedback and without. Table 3 shows the most sensitive parameters for the model with feedback; all of these parameters represent potential targets for type 2 diabetes therapy. Decreasing values of parameters with negative sensitivities or increasing values of parameters with positive sensitivities would result in higher GLUT4 surface percentages, which, in turn, would lead to higher steady-state rates of glucose transport and lower blood glucose levels.
In addition, one can compare the steady-state performance of the model with feedback mechanisms and the model without (Table 4 ). The parameter sensitivity increased the most by the removal of feedback, k −12 , describes the deactivation of PKCζ; this is indicative of the negative feedback loop involving active PKCζ. As expected from the positive feedback loop involving active Akt, the sensitivity of GLUT4 translocation to k −11 , which describes deactivation of Akt, is the one decreased most by the removal of feedback.
STOCHASTIC MODELING
Because a number of model species have small copy counts per cell volume (fewer than 10), fluctuations in copy counts may have a profound effect on model behavior (Giri et al. [2004] ). As a result, we developed and simulated a stochastic version of Sedaghat's insulin signaling pathway model using Gillespie's stochastic simulation algorithm (SSA), implemented in the StochKit software package (Gillespie [1976] ). 
Methods
A stochastic model was derived from the Sedaghat model with feedback by assuming the differential equations could be represented explicitly as elementary reactions. A nominal system volume of 0.93 nL, the size of a typical human adipocyte, was chosen (Leonhardt et al. [1972] ). Using the system volume, initial concentrations were converted to species populations. For variables in the deterministic model that had units of percentage (e.g. x 21 is the percentage of total GLUT4 at the cell surface), estimates of concentrations for these variables were taken from the literature and used to calculate these chemical species' initial populations (Giri et al. [2004] ).
Deterministic kinetic parameters were converted to the appropriate stochastic forms, and kinetic parameters that were functions of state variables in the Sedaghat model were included in StochKit by adding custom code to the propensity functions. Additional custom code was written to simulate the 15-minute pulse of insulin input and the explicit time delay that appear in the Sedaghat model (Sedaghat et al. [2002] ).
Two sets of perturbation simulations were then done on the stochastic model to study the sensitivity of fluctuation magnitude. One set of simulations involved varying the system volume up and down 10-fold to study the effect of cell volume. In the other set of simulations, "sensitive" and "insensitive" reaction rates from the deterministic model (k −9 and k −1 respectively) were increased and decreased by 50%, holding volume constant, to give us a qualitative feel for the effect of these parameter perturbations on the stochastic model.
Results and analysis
As seen in Fig. 2 , the stochastic trajectories tend to peak below the deterministic model, especially at small volumes. This difference is primarily due to a variable in the Sedaghat model that describes the combined effect activated Akt and PKCζ have on the GLUT4 translocation rate to the cell surface -this "effect" has an upper bound in the model. Therefore, stochastic fluctuations in the amount of activated Akt and PKCζ near their peak values that would ordinarily raise the "effect" variable above the upper bound are capped while fluctuations below the deterministic values lead to lower surface GLUT4 (x 21 ) translocation propensities and lower surface GLUT4 values at peak stimulation.
Another observation to be made from Fig. 2 is that the stochastic model trends slightly above the deterministic model near the end of the numerical experiments (at approximately 50 minutes). This is primarily due to stochastic fluctuations in x 13 around the deterministic steady- The magnitude of fluctuations in x 21 (surface GLUT4) increased from ≈10% to ≈25% when the volume was decreased 10-fold and reduced to ≈5% when volume was increased 10-fold. As seen in Fig. 3 , a 50% change in k −1 , an insensitive parameter, resulted in negligible change in peak value or relative fluctuation magnitude, while a 50% change in k −9 , a sensitive parameter, caused a ≈20% change in x 21 peak value, with negligible effect on relative fluctuation magnitude. By comparing the two sets of stochastic experiments, we can argue that relative fluctuation magnitude depends primarily on volume and remains largely independent of parameter values, while peak values depend both on volume and the values of sensitive parameters.
CONCLUSION
In this paper, sensitivity analysis was used to minimize error in parameter estimation by optimization of input perturbation selection as well as state measurement selection. With model parameters gleaned from analysis of dynamic sensitivity, steady-state sensitivity analysis revealed a number of sensitive parameters suitable for drug targeting; also, we found that the addition of feedback mechanisms significantly changes the sensitivities with respect to a number of parameters. Finally, we used stochastic modeling to determine that system volume and parameter perturbations may have effects on the response of GLUT4 to insulin that are not captured by a deterministic model.
A number of criticisms can be leveled at this work; one possibility is that, although a number of parameters were removed due to a priori unidentifiability, more model parameter reduction possibly could have been done, as only 68% of the parameters were identifiable. Other possible criticisms include the fact that realistic state measurement data does not tend to be as continuous or as accurate as this analysis assumes (0.001 min per data point with 1% measurement error). More realistic numbers of time points and larger state measurement errors would likely result in fewer identifiable parameters with larger estimated variances. In addition, numerical inversion of a nearly singular FIM was needed to calculate estimated parameter variances which could have led to numerical errors.
Further work should include model validation, using the input and measurement selection developed here to determine parameters more closely and/or invalidate the model. A more comprehensive search on input perturbations and measurement selection may yield better results for parameter estimation. Incorporating expected fluctuation magnitude from our stochastic experiments into our input and measurement selections may result in a more realistic set of parameters identifiable from experiment.
In the course of developing this sensitivity analysis and the stochastic realization of the Sedaghat model, we found a number of shortcomings in the Sedaghat model. While portions of the model follow standard mass-action kinetics, we found a number of places in which the model was not mechanistically detailed. This led to a number of difficulties in our work -primarily in our stochastic simulations. We believe that further development of a more detailed model will be important to our understanding of insulin signaling. Incorporating recently discovered signaling components, such as those discussed by Schmelzle et al. [2006] and by Saltiel and Pessin [2003] may be useful.
Lastly, because insulin affects a number of other cellular processes, the integration of crosstalk (Sesti [2006] ) or models that incorporate organism-level detail (e.g. pancreatic β-cell secretion of insulin) (Bertuzzi et al. [2007] , Topp et al. [2000] ) would yield a more complete understanding of the role of the insulin signaling cascade on glucose disposal and insulin resistance.
